Home
2333
2222222222
fallaga
About PhaseBio
Mission and Strategy
Management
Board of Directors
Clinical Advisors
Technology
Core Technology
Advantages of ELP Biopolymers
Therapeutic Focus
Type 2 Diabetes and Obesity
PB1023: A long-acting GLP-1 analogue
Insumera: A long-acting native insulin
Cardiovascular Disease
Vasomera™: A long acting VIP analogue
Clinical Development Pipeline
PB1023
Vasomera™
Insumera
Newsroom
In The News
Key Presentations & Publications
Investors
Careers
Contact Us
Vasomera Abstracts Accepted for Presentation at the American Heart Assoc. Scientific Sessions
Refer to "Events" for details.
Back to In the News